정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 464 | Withdrawn | Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise | Covid19 | Biological: COVI-MSC | Phase 2 | Sorrento Therapeutics, Inc. | INDUSTRY | 0 | All | 18 Years | |
| 463 | Not yet recruiting | Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise | Covid19 | Biological: COVI-MSC Biological: Placebo |
Phase 2 | Sorrento Therapeutics, Inc. | INDUSTRY | 60 | All | 18 Years | |
| 462 | Not yet recruiting | Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine | SARS-CoV-2 Acute Respiratory Disease | Biological: SARS-Cov-2 mRNA vaccine immunization Biological: Inactivated SARS-Cov-2 vaccine immunization |
Not Applicable | Qihan Li | OTHER | 112 | All | 18 Years | |
| 461 | Completed | Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation | COVID-19 | Biological: Ampion Other: Standard of Care |
Phase 1 | Ampio Pharmaceuticals. Inc. | INDUSTRY | 10 | All | 18 Years ~ 89 Years | Research Site, Colorado Springs, Colorado, United States |
| 460 | Active, not recruiting | Study of AZD1222 for the Prevention of COVID-19 in Japan | COVID-19 | Drug: AZD1222 Drug: 0.9% (w/v) saline |
Phase 2 | AstraZeneca, Iqvia Pty Ltd | INDUSTRY | 256 | All | 18 Years | Research Site, Fukuoka-shi, Japan Research Site, Hachioji-shi, Japan Research Site, Minato-ku, Japan Research Site, Sumida-ku, Japan Research Site, Toshima-ku, Japan |
| 459 | Completed | Study of Codivir in Patients With COVID-19 | Covid19 | Drug: Covidir injections Diagnostic Test: One Step Test Diagnostic Test: IgM and IgG dosage Diagnostic Test: RT-PCR SARS-CoV-2 Diagnostic Test: Screening blood test Diagnostic Test: ECG Diagnostic Test: Medical evaluation Diagnostic Test: NEWS-2 score Diagnostic Test: WHO score |
Phase 1 | Code Pharma | INDUSTRY | 12 | All | 18 Years ~ 60 Years | Hospital Vera Cruz S A (Campinas-SP), Campinas, State Of Sao Paulo, Brazil |
| 458 | Completed | Study of COVID-19 DNA Vaccine (AG0301-COVID19) | COVID-19 | Biological: AG0301-COVID19 Biological: AG0301-COVID19 |
Phase 2 | AnGes, Inc., Japan Agency for Medical Research and Development | INDUSTRY | 30 | All | 20 Years ~ 65 Years | Osaka City University Hospital, Osaka, Japan |